Huel Impact on Inflammation Markers Study
This study explores how Huel, a nutritionally complete food, affects inflammation markers like C-Reactive protein, neutrophils, TNF-alpha, IL-10, and IL-6 in adults.
Huel
Inflammation
+ Pathologic Processes
+ Pathological Conditions, Signs and Symptoms
Basic Science Study
Summary
Study start date: February 1, 2025
Actual date on which the first participant was enrolled.This study is exploring how Huel, a nutritionally complete food product, affects indicators of inflammation in the digestive system of generally healthy people. The research involves 30 participants and focuses on detecting any changes in nine specific markers that indicate the level of inflammation. This is important for understanding whether consuming Huel can influence inflammation, which is linked to various health conditions and could lead to better dietary recommendations or treatments in the future. Participants will first continue their usual diets for one week while their inflammation markers are measured. Then, they will consume two ready-to-drink Huel products each day, one Hot & Savoury Huel meal, and the rest of their calories from Huel Powder (v3.1) for four weeks. This study measures changes in inflammation markers from the start, after the habitual diet period, and after the Huel consumption period to assess any impact. The process is designed to gather data on how dietary changes might affect inflammation in the body.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.30 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Basic Science Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: Generally healthy Aged 18 years and over Non-pregnant, Non-lactating non-smoking Exclusion Criteria: Smoker Pregnant Lactating BMI \>30 Food allergy Disordered eating Disorder which could impact the study outcomes Medications which could impact the study outcomes
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Faculty of Medical Sciences
Newcastle upon Tyne, United KingdomOpen Faculty of Medical Sciences in Google Maps